Inflammatory Arthritis
Rheumatoid arthritis and psoriatic arthritis are key areas of interest, with research focused on improving disease control and achieving remission in people living with chronic joint inflammation.
- Biologic therapies
- Clinical disease activity assessment
- Disease remission in inflammatory arthritis
Work in this area reflects a strong therapeutic focus on immune-mediated joint disease and treatment strategies aimed at reducing persistent inflammation.
Head and Neck Cancer
Research activity includes HPV-positive oropharyngeal cancer, with attention to treatment approaches that preserve swallowing function while managing tumour control after surgery.
- Transoral surgery
- Adjuvant treatment for oropharyngeal cancer
- Functional outcomes in head and neck oncology
This area links cancer treatment with recovery of everyday functions affected by therapy.
Anal Cancer
Anal cancer studies are centred on combining immune checkpoint inhibition with standard chemoradiation in locally advanced disease.
- Pembrolizumab
- Chemoradiation in anal cancer
- Safety and tolerability of combined cancer treatment
The therapeutic interest is in integrating immunotherapy with established oncologic treatment for locally advanced malignancy.
Blood Cancer
Studies in blood cancer include Philadelphia chromosome-positive acute lymphoblastic leukemia, with interest in targeted treatment combined with chemotherapy.
- Tyrosine kinase inhibitors
- Acute lymphoblastic leukemia
- Combination therapy in hematologic malignancy
This research domain reflects involvement in molecularly targeted treatment for aggressive hematologic disease.
